Removal of BRCA1/CtIP/ZBRK1 repressor complex on ANG1 promoter leads to accelerated mammary tumor growth contributed by prominent vasculature

被引:98
作者
Furuta, Saori [1 ]
Wang, Ju-Ming [1 ]
Wei, Shuanzeng [1 ]
Jeng, Yung-Ming [1 ]
Jiang, Xianzhi [1 ]
Gu, Bingnan [1 ]
Chen, Phang-Lang [1 ]
Lee, Eva Y. -H. P. [1 ]
Lee, Wen-Hwa [1 ]
机构
[1] Univ Calif Irvine, Coll Med, Dept Biol Chem, Irvine, CA 92697 USA
关键词
D O I
10.1016/j.ccr.2006.05.022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BRCA1 exerts transcriptional repression through interaction with CUP in the C-terminal BRCT domain and ZBRK1 in the central domain. A dozen genes, including angiopoietin-1 (ANG1), a secreted angiogenic factor, are corepressed by BRCA1 and CUP based on microarray analysis of mammary epithelial cells in 3D culture. BRCA1, CUP, and ZBRK1 form a complex that coordinately represses ANG1 expression via a ZBRK1 recognition site in the ANG1 promoter. Impairment of this complex upregulates ANG1, which stabilizes endothelial cells that form a capillary-like network structure. Consistently, Brca1-deficient mouse mammary tumors exhibit accelerated growth, pronounced vascularization, and overexpressed ANG1. These results suggest that, besides its role in maintaining genomic stability, BRCA1 directly regulates the expression of angiogenic factors to modulate the tumor microenvironment.
引用
收藏
页码:13 / 24
页数:12
相关论文
共 47 条
[31]   Two waves of nuclear factor κB recruitment to target promoters [J].
Saccani, S ;
Pantano, S ;
Natoli, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (12) :1351-1359
[32]   Interaction between a cellular protein that binds to the C-terminal region of adenovirus E1A (CtBP) and a novel cellular protein is disrupted by E1A through a conserved PLDLS motif [J].
Schaeper, U ;
Subramanian, T ;
Lim, L ;
Boyd, JM ;
Chinnadurai, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (15) :8549-8552
[33]  
Shekhar MPV, 2000, CANCER RES, V60, P439
[34]   Familial invasive breast cancers:: Worse outcome related to BRCA1 mutations [J].
Stoppa-Lyonnet, D ;
Ansquer, Y ;
Dreyfus, H ;
Gautier, C ;
Gauthier-Villars, M ;
Bourstyn, E ;
Clough, KB ;
Magdelénat, H ;
Pouillart, P ;
Vincent-Salomon, A ;
Fourquet, A ;
Asselain, B .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (24) :4053-4059
[35]   A DNA vector-based RNAi technology to suppress gene expression in mammalian cells [J].
Sui, GC ;
Soohoo, C ;
Affar, E ;
Gay, F ;
Shi, YJ ;
Forrester, WC ;
Shi, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (08) :5515-5520
[36]   Requisite role of Angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis [J].
Suri, C ;
Jones, PF ;
Patan, S ;
Bartunkova, S ;
Maisonpierre, PC ;
Davis, S ;
Sato, TN ;
Yancopoulos, GD .
CELL, 1996, 87 (07) :1171-1180
[37]   A role for hematopoietic stem cells in promoting angiogenesis [J].
Takakura, N ;
Watanabe, T ;
Suenobu, S ;
Yamada, Y ;
Noda, T ;
Ito, Y ;
Satake, M ;
Suda, T .
CELL, 2000, 102 (02) :199-209
[38]   Functional dissection of transcription factor ZBRK1 reveals zinc fingers with dual roles in DNA-binding and BRCA1-dependent transcriptional repression [J].
Tan, W ;
Zheng, L ;
Lee, WH ;
Boyer, TG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (08) :6576-6587
[39]   Transcriptional activation of the cyclin A gene by the architectural transcription factor HMGA2 [J].
Tessari, MA ;
Gostissa, M ;
Altamura, S ;
Sgarra, R ;
Rustighi, A ;
Salvagno, C ;
Caretti, G ;
Imbriano, C ;
Mantovani, R ;
Del Sal, G ;
Giancotti, V ;
Manfioletti, G .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (24) :9104-9116
[40]   DECREASED EXPRESSION OF BRCA1 ACCELERATES GROWTH AND IS OFTEN PRESENT DURING SPORADIC BREAST-CANCER PROGRESSION [J].
THOMPSON, ME ;
JENSEN, RA ;
OBERMILLER, PS ;
PAGE, DL ;
HOLT, JT .
NATURE GENETICS, 1995, 9 (04) :444-450